Pain, Post-operative Clinical Trial
Official title:
A Phase 2, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety, Efficacy, and Pharmacokinetics of N1539 Following Bunionectomy
The primary objective of this study is to evaluate the safety of N1539 in subjects with acute moderate to severe pain following unilateral bunionectomy.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02284243 -
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery
|
Phase 2 | |
Completed |
NCT02720692 -
Evaluation of N1539 Following Major Surgery
|
Phase 3 | |
Completed |
NCT03456141 -
Multimodal Analgesic Protocol to Moderate Acute Pain
|
||
Terminated |
NCT02169336 -
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy
|
Phase 2 | |
Not yet recruiting |
NCT05950152 -
Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery
|
Phase 2 | |
Completed |
NCT02678286 -
Evaluation of N1539 Following Abdominoplasty Surgery
|
Phase 3 | |
Completed |
NCT02675907 -
Evaluation of N1539 Following Bunionectomy Surgery
|
Phase 3 | |
Unknown status |
NCT01041313 -
Memantine for Post-Operative Pain Control
|
Phase 4 | |
Completed |
NCT03154658 -
Serratus Anterior Plane Block in Patients Undergoing Mastectomy
|
Phase 4 |